P. Neuenschwander

发表

Electrospun Fibers as a Dressing Material for Drug and Biological Agent Delivery in Wound Healing Applications

S. Chou, Mulugeta Gizaw, Jeffrey Y. Thompson, 2018, Bioengineering.

Inhibition of Platelet Adhesion from Surface Modified Polyurethane Membranes

S. Chou, A. Azghani, P. Neuenschwander, 2020, Biomedical journal of scientific & technical research.

An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.

P. Neuenschwander, J. Morrissey, M. Fiore, 1992, Blood.

The use of acetylated factor X to prevent feedback activation of factor VIII during factor X activation: a tool for kinetic studies.

J. Jesty, P. Neuenschwander, 1990, Analytical biochemistry.

A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X

J. Jesty, P. Neuenschwander, 1988 .

Delivery of GM-CSF to Protect against Influenza Pneumonia

H. Shams, R. Subramaniam, P. Neuenschwander, 2015, PloS one.

Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody.

C. Esmon, P. Neuenschwander, A. Rezaie, 1992, Protein expression and purification.

Factor VIIa-Tissue Factor: Functional Importance of Protein-Membrane Interactions

P. Neuenschwander, A. Johnson, J. Morrissey, 1997, Thrombosis and Haemostasis.

Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism.

P. Neuenschwander, J. Morrissey, M. Fiore, 1993, The Journal of biological chemistry.

COAGULATION CASCADE | Overview

P. Neuenschwander, 2006 .

COAGULATION CASCADE | Factor V

P. Neuenschwander, 2006 .

COAGULATION CASCADE | Intrinsic Factors

P. Neuenschwander, 2006 .

Primes Dendritic Cells To Stimulate Th17 Mycobacterium tuberculosis Protein of Early Secreted Antigenic Target of 6-kDa

D. Sherman, B. Samten, P. Barnes, 2012 .

Analysis of Cre-loxP interaction by surface plasmon resonance: influence of spermidine on cooperativity.

B. Sauer, P. Neuenschwander, A. Rüfer, 2002, Analytical biochemistry.

Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.

C. Ruppert, E. Abraham, S. Shetty, 2010, American journal of respiratory and critical care medicine.

The Location of the Active Site of Blood Coagulation Factor VIIa above the Membrane Surface and Its Reorientation upon Association with Tissue Factor

P. Neuenschwander, J. Morrissey, A. Johnson, 1996, The Journal of Biological Chemistry.

Engineering Approaches to Prevent Blood Clotting from Medical Implants

S. Chou, P. Neuenschwander, A. C. Wilson, 2019, Archives in biomedical engineering & biotechnology.

Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation

P. Comp, P. Neuenschwander, B. G. Macik, 1993 .

Tissue Factor Positions and Maintains the Factor VIIa Active Site Far above the Membrane Surface Even in the Absence of the Factor VIIa Gla Domain

J H Morrissey, P. Neuenschwander, J. Morrissey, 1997, The Journal of Biological Chemistry.

Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.

P. Comp, J H Morrissey, P C Comp, 1993, Blood.

Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.

P. Neuenschwander, J. Morrissey, 1994, The Journal of biological chemistry.

Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: importance of amino acid residue K192.

P. Neuenschwander, J. Morrissey, 1995, Biochemistry.

Substrate Recognition by Tissue Factor-Factor VIIa

P. Neuenschwander, A. Rezaie, J. Morrissey, 1996, The Journal of Biological Chemistry.

Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance

P. Sen, U. Pendurthi, P. Neuenschwander, 2010, Blood Coagulation and Fibrinolysis.

Heparin Modulates the 99-Loop of Factor IXa

P. Neuenschwander, Stephen R. Williamson, A. Nalian, 2006, Journal of Biological Chemistry.

Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis.

M. A. Payne, J H Morrissey, P. Neuenschwander, 1996, Biochemistry.

Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.

P. Neuenschwander, J. Morrissey, 1992, The Journal of biological chemistry.

Analysis of the functions of the first epidermal growth factor-like domain of factor X.

C. Esmon, P. Neuenschwander, A. Rezaie, 1993, The Journal of biological chemistry.

Importance of Substrate Composition, pH and Other Variables on Tissue Factor Enhancement of Factor Vlla Activity

D. Branam, P. Neuenschwander, J. Morrissey, 1993, Thrombosis and Haemostasis.

Thermal and Physico-Mechanical Characterizations of Thromboresistant Polyurethane Films

Jonathan Y. Chen, S. Chou, P. Neuenschwander, 2019, Bioengineering.

Water Content and Thermoplastic Polyurethane Effects on Thrombosis Clotting

S. Chou, P. Neuenschwander, M. Small, 2019 .

Nanostructure-Enabled and Macromolecule-Grafted Surfaces for Biomedical Applications

S. Chou, Addison Faglie, P. Neuenschwander, 2018, Micromachines.

Correlation of factor IXa subsite modulations with effects on substrate discrimination

P. Neuenschwander, K. Zepeda, K. Deadmond, 2012, Journal of thrombosis and haemostasis : JTH.

Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.

P. Neuenschwander, Pierre F Neuenschwander, 2004, Biochemistry.

factor mutant selectively deficient in promoting factor VII activation Quantitation of activated factor VII levels in plasma using a tissue

P. Neuenschwander, B. G. Macik, J. Morrissey, 2011 .

The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.

P. Neuenschwander, A. Kurdowska, K. Stephenson, 2013, International journal of pharmaceutical compounding.

Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages

H. Shams, R. Subramaniam, P. Neuenschwander, 2015, Mucosal Immunology.

Early Secreted Antigenic Target of 6-kDa Protein of Mycobacterium tuberculosis Primes Dendritic Cells To Stimulate Th17 and Inhibit Th1 Immune Responses

D. Sherman, B. Samten, P. Barnes, 2012, The Journal of Immunology.

The intrinsic ATPase activity of Mycobacterium tuberculosis DnaA promotes rapid oligomerization of DnaA on oriC

M. Madiraju, M. Rajagopalan, J. Grimwade, 2006, Molecular microbiology.

Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function*

C. Esmon, P. Liaw, P. Neuenschwander, 2000, The Journal of Biological Chemistry.

Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.

G. Morris, S. Shetty, Y. Bhandary, 2013, The American journal of pathology.

The β-propeller gene Rv1057 of Mycobacterium tuberculosis has a complex promoter directly regulated by both the MprAB and TrcRS two-component systems.

S. T. Howard, Xiuhua Pang, Guangxiang Cao, 2011, Tuberculosis.

Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.

P. Neuenschwander, A. Rezaie, J. Morrissey, 1995, Biochemistry.

A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.

J Jesty, J. Jesty, P. Neuenschwander, 1988, Blood.

Coagulation Cascade: Overview

P. Neuenschwander, 2021, Reference Module in Biomedical Sciences.

Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2

Fan Yang, Ke Du, R. Vankayalapati, 2021, ACS omega.

The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa.

P. Neuenschwander, J. Morrissey, M. Fiore, 1994, The Journal of biological chemistry.

Substrate Recognition by Tissue Factor-Factor VIIa EVIDENCE FOR INTERACTION OF RESIDUES Lys AND Lys OF TISSUE FACTOR WITH THE 4-CARBOXYGLUTAMATE-RICH DOMAIN OF FACTOR X*

P. Neuenschwander, A. Rezaie, J. Morrissey, 1996 .

Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.

James H Morrissey, P. Neuenschwander, J. Morrissey, 2002, Biochemistry.

Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production.

V. Boggaram, P. Barnes, H. Shams, 2014, The Journal of infectious diseases.

A Review of Injectable and Implantable Biomaterials for Treatment and Repair of Soft Tissues in Wound Healing

S. Chou, Huarong Nie, P. Neuenschwander, 2017 .

Inhibit Th 1 Immune Responses Primes Dendritic Cells To Stimulate Th 17 Mycobacterium tuberculosis Protein of Early Secreted Antigenic Target of 6-kDa

D. Sherman, B. Samten, P. Barnes, 2012 .

Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.

J. Jesty, P. Neuenschwander, Jolyon Jesty, 1992, Archives of biochemistry and biophysics.

Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.

C. Ruppert, E. Abraham, S. Shetty, 2010, American journal of respiratory and critical care medicine.

Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.

P. Neuenschwander, J. Morrissey, D. L. Warren, 1999, Biochemistry.